Crescent Ventures Leads $10M Round for CrossBridge Bio

CE-Ventures, the venture capital arm of UAE-based Crescent Enterprises, and TMC Venture Fund have co-led a $10 million funding round for CrossBridge Bio, a Houston-based biotech firm, with participation from Portal Innovations, Alexandria Ventures, and Linden Lake Labs.

More to Know:

  • CrossBridge Bio was founded in 2023 by Michael Jason Torres.
  • The startup focuses on developing therapeutics, particularly for solid tumours.

 

 

 

 

 

مقالات ذات صلة

PRYPCO, a UAE-based proptech platform, has raised $10 million in a seed...

SETTLE PAYMENTS, the Egyptian fintech platform, has raised $2 million in a...

Wa’ed Ventures, an Aramco-owned VC fund, has allocated $100 million to invest...